Introduction {#Sec1}
============

National Electrical Manufacturers Association (NEMA) NU 2-2007^[@CR1]^ and NU 2-2012^[@CR2]^ standards constitute a set of methods under specific conditions that allow estimating the performance evaluation and comparison of Positron Emission Tomograph (PET) scanners. NU 2-2007 is expressly intended for Whole Body PETs (WB-PET) and NU 2-2012 presents minor modifications of the previous protocol. The measurements performed by these standards are the spatial resolution, sensitivity, counting rate performance, accuracy (correction for count losses and randoms) and image quality (accuracy of attenuation and scatter corrections).

In this work, we present the performance evaluation of the dedicated brain PET CareMiBrain based on NU 2-2012 and NU 4-2008^[@CR3]^ (dedicated to preclinical equipment). The reason for including the small animal standard is the reduced dimensions of the CareMiBrain scanner (260 mm of gantry). Finally, we compare the performance evaluation for the most used WB-PETs and dedicated brain PETs found in the literature that fulfills the NEMA procedures. Some of these studies used the standard NU-2007 and therefore it is also included in this study. Table [1](#Tab1){ref-type="table"} shows the phantoms used in each standard and the main differences between them. Detailed information can be found in^[@CR1]--[@CR3]^.Table 1NEMA Measurements performed in this study and its main differences.MeasurementPhantom/Reconstruction DetailsDifferencesNU 4-2008NU 2-2007NU 2-2012Spatial ResolutionEncapsulated ^22^Na Source. Reconstructed with FBPCapillary filled with ^18^F. Reconstructed with FBPCapillary filled with ^18^F. Reconstructed with FBP- Different positions for all three protocols- 2012 admits alternative iterative algorithms but is mandatory FBP reportingScatter fraction, count losses, random coincidences measurementsCylindrical polyethylene phantom. Different dimensions for mouse, rat and monkeyCylindrical polyethylene phantom for whole body.Cylindrical polyethylene phantom for whole body.- Different phantom in 2008- Different phantom positioning and different tolerances for the activity filling between 2007--2012SensitivityEncapsulated ^22^Na SourceCapillary filled with ^18^F and different sleeves sizes phantomCapillary filled with ^18^F and different sleeves sizes phantom- Different phantom in 2008- Slightly different parameter calculation and tolerances for the activity filling between 2007--2012.Image Quality, accuracy of attenuation correction and scatter correctionCustomized phantom that includes uniformity region, rods and cold rods (air/water). Filled with ^18^FCustomized phantom that includes: uniformity region, lung insert, and 6 spheres (hot regions). Filled with ^18^FCustomized phantom that includes: uniformity region, lung insert, and 6 spheres (hot regions). Filled with ^18^F- Different phantom in 2008- Different phantom positioning, acquisition time and different tolerances for the activity filling between 2007--2012Accuracy: corrections for count losses and randomsNot IncludedThe same phantom as the scatter fraction testThe same phantom as scatter fraction test- Different phantom positioning and different tolerances for the activity filling between 2007--2012- The reconstructed image values are compared to different references between 2007--2012

Materials and Methods {#Sec2}
=====================

CareMiBrain is a brain dedicated PET system developed by Oncovision S.A. (Spain). This device consists of three detector rings with 16 detector modules each forming a transaxial gantry of 256 mm and an axial length of 154 mm. Each detector module includes a 50 × 50 × 15 mm^3^ monolithic Lutetium Yttrium OrthoSilicate (LYSO) crystal (non-pixelated) coupled to a photosensor array of 12 × 12 Silicon PhotoMultiplier (SiPM) of the C-Series type from SensL (Cork, Ireland). All surfaces of the scintillation blocks are polished and the lateral ones are black-painted. The 50 × 50 mm^2^ entrance surface includes a retro-reflecting layer which bounces back the scintillation light to the point of emission. Coincidence timing window is 5 ns and the overall energy resolution is about 17%. The detectors have their own electronic board including the power supply, for both the SiPM and the electronics on the module (see Fig. [1](#Fig1){ref-type="fig"}).Figure 1Image of the CareMiBrain system (left), detail of the detector electronics (center), crystal configuration (right).

CareMiBrain dimensions cover more than 95% of the patient's percentile based on a 3D anthropometric database of the population framed in the INTERREG IVB SUDOE program^[@CR4]^ carried out by the Biomechanics Institute of Valencia. During the scan, the patient is seated and the detector is placed surrounding the head (Fig. [1](#Fig1){ref-type="fig"}) leaving space for open eyes and visual external stimuli studies. The whole scanner footprint is 1.2 × 2.5 m^2^.

The most noticeable technological feature in comparison to other PET scanners is the use of a single monolithic crystal per module instead of small pixelated crystal arrays. Monolithic crystals together with the proprietary readout electronics have the advantage of a high resolution (1 mm) determination of the Depth Of Interaction (DOI) of the gamma rays inside the scintillation crystal thickness^[@CR5]^. The (x, y) coordinates are obtained summing the 12 × 12 channels in columns and rows and applying the Raised to the Power (RTP) method^[@CR5]^.

CareMiBrain works in 3D data acquisition mode. The transaxial Field of View (FOV) is defined by the number of modules in the detection ring and the acceptance angles of impinging photons. Coincidences among a detector and its nine opposite detector modules belonging to the same ring and the others are allowed during the acquisition. We define a pair detector as the two modules that can trigger an event. Therefore, the scanner has 648 possible pairs. Given the number of pairs, the number of Lines of Response (LOR) is determined by the virtual pixel dimension chosen. In this work, the pixels used are 2 mm × 2 mm, thus, we consider about 180 M LORs during the acquisition and reconstruction process.

Direct normalization method^[@CR6]^ is applied to obtain a geometrical-free-artifact reconstructed image. To obtain the correction factors for normalization a ^22^Na cylindrical phantom with uniform activity (14.79 MBq) with a diameter and height of 240 mm and 150 mm respectively was, situated in the FOV and acquired during 20 hours.

Spatial resolution {#Sec3}
------------------

The spatial resolution of a system represents its ability to distinguish between two points after image reconstruction. The measurement of spatial resolution was performed according to both standards. For the preclinical standard a ^22^Na point source (a sphere with 0.3 mm diameter embedded in an acrylic cube of 10.0 mm) with an activity of 370 kBq (July 2011) was used. The source was located at the axial center of the FOV, and one-fourth of the axial FOV from the center of the axial FOV, at radial distances from the center of 0, 5, 10, 15, 25, 50, 75 and 100 mm. Each measurement took 300 seconds.

Following WB-PET PET standard performance, a capillary glass tube with ^18^F-FDG (FluoroDeoxyGlucose) was used, with an inner and outer diameter of 1 and 2 mm respectively. The starting activity was 121 kBq with a length of 1 mm inside the tube. The source was located at the axial center of the FOV, and three-eighths of the axial FOV from the center of the axial FOV, at 10 and 100 mm from the center in a radial direction. Each measurement took 300 seconds.

The experiments were repeated thrice. The acquisitions were reconstructed using 2D-Filtered BackProjection algorithm (FBP)^[@CR7]^ with Single Slice ReBining method (SSRB)^[@CR6]^, using an energy window of 30% and were analyzed according to their NEMA standards.

Scatter fraction and count rate measurements {#Sec4}
--------------------------------------------

The objective of these measurements is to obtain system performance curves. These curves are the result of the analysis of the acquisitions in which the data are sorted into sinograms by SSRB, and processed to obtain an estimation of the true and random-scattered coincidences. With this aim and assuring certain conditions, several measures must be taken starting with an activity that guarantees the saturation of the detector until the detection of radiation is negligible. The Scatter Fraction (SF) estimation is performed with low activity rates ensuring the absence of random coincidences.

In our case, scatter fraction and count rates tests were performed following WB-PET specifications (Fig. [2c](#Fig2){ref-type="fig"}). The phantom described in this standard was placed in the center of the tomograph employing support specifically designed for this purpose, achieving the same position as indicated for WB-PET devices.Figure 2(**a**) Centered sensitivity NU 2-2012 phantom. (**b**) Phantom displaced 100 mm off the central axis. (**c**) Count rate performance measurement. (**d**) Image quality test. The custom phantom is placed on the support inside the tomograph.

In our case, each measurement lasted 100 seconds, with a delay time of 300 seconds in between acquisitions. The initial activity of the line source was 602.5 MBq. The SF estimation following NEMA indications was performed with acquisitions in the range of 7.4--14.8 MBq. The energy window used was 50%.

Sensitivity {#Sec5}
-----------

Sensitivity is a measure that indicates how many true coincidence events have been detected for a given source. For this purpose, a source is placed along the axial axis in order to acquire data over the entire length of the scanner. These acquired data are processed according to the standards to obtain a sensitivity value, utilizing analysis of sinograms (in case of NU 4-2008) or data extrapolation (in case of NU 2-2012).

According to NU 4-2008, the same solid source as in spatial resolution section is used to perform this measurement. In our case, the source was placed at the center of the transaxial FOV and moved along it in steps of 2 mm. The duration of each acquisition was 180 seconds.

According to NU 2-2012, we used the sensitivity phantom described in the standard. 600 seconds scans were taken with the 5 sets of aluminium sleeves with increasing thickness. The phantom was suspended in the center of the transaxial FOV, aligned with the axis of the tomograph. This measurement was repeated at 100 mm off the central axis (Fig. [2a,b](#Fig2){ref-type="fig"}). A 700 mm length plastic tube was used and filled with water mixed with ^18^F-FDG with an initial activity of 12.56 MBq for the center test and 7.16 MBq for the off-center test.

Two energy windows were considered: 355 to 664 keV (30%) and 255 to 765 keV (50%) for both standards.

Image quality, the accuracy of attenuation and scatter corrections {#Sec6}
------------------------------------------------------------------

The main objective of image quality testing is the measurement of Recovery Coefficients (RC). The recovery coefficients evaluate the system ability to discern hot or cold lesions contained in a radioactive background, giving an idea of the reconstructed image quality taking into account corrections for scattering, random counts, lost counts, positron range and partial volume effect. The spill-over ratio (SOR) is the ratio of the mean in each cold region and the mean of the hot uniform area.

WB-PET standard uses a torso-like phantom, while the preclinical standard has its own phantom. Dedicated tomographs have a very specific application and NEMA phantoms are not the most appropriate. With this motivation, we designed a custom phantom, with dimensions closer to a human head; 135 mm diameter and 103 mm height. Inside, six independent cylindrical rods with 50 mm height and diameters of 20, 15, 12, 9, 6 and 4.5 mm are placed (Fig. [3](#Fig3){ref-type="fig"}). The phantom designed is able to evaluate the recovery coefficients from 4.5 mm to 20 mm within a radioactive background covering the range of spatial resolutions provided by WB-PET scanners reported in the literature. The values of RC, SOR and their standard deviations were calculated based on the procedure described in NU 4-2008.Figure 3Image quality phantom.

For the measurements, the containing cylinder was filled with 5.3 kBq/ml of ^18^F-FDG and the four small rods were filled at a 4:1 ratio. The rod of 15 mm was filled with non-radioactive water while the 20 mm rod contained only air. The acquisition lasted 1200 seconds and was processed using an energy window of 30%. To simulate the activity outside of the FOV, the count rate phantom was placed on the sofa with a linear source of 116 MBq (Fig. [2d](#Fig2){ref-type="fig"}). Finally, a reconstructed image of a patient from Hospital Clinico San Carlos from Madrid (Spain) is shown in this work. The acquisition took 660 seconds and the activity injected at the moment of the acquisition was 123 MBq.

The acquisitions were reconstructed using List Mode Ordered Subsets algorithm (LMOS)^[@CR8]^ with 3 iterations, 12 subsets, voxel size of 1 × 1 × 1 mm^3^ and virtual crystal pixel size of 2 × 2 mm^2^. The scatter correction is based on the dual-energy window method^[@CR9]^, whereas the random correction follows the single rate method^[@CR10]^. The attenuation correction is performed using an attenuation map generated by segmentation of the reconstructed image^[@CR11]^. In the case of the phantom, two different materials were considered for attenuation map: air and tissue. However, in the patient image, three attenuation materials were considered: air, bone and tissue. No further post-processing filters were applied.

Compliance with ethical standards {#Sec7}
---------------------------------

The patient image shown is part of studies were all procedures performed are in accordance with the ethical standards of the Hospital Clinico San Carlos and in-agreement with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

The patient showed in Fig. [6](#Fig6){ref-type="fig"} gave his informed consent to study participation.

Results {#Sec8}
=======

Spatial resolution {#Sec9}
------------------

Tables [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"} collect the values obtained for spatial resolution. The difference between source sizes affects spatial resolution results.Table 2Spatial resolution (NEMA NU 4-2008).Reconstructed image pixel size (mm): 0.25 mm\
Slice thickness (mm): 0.25 mm\
At axial center5 mm10 mm15 mm25 mmFWHMFWTMFWHMFWTMFWHMFWTMFWHMFWTMRadial1.512.751.582.871.642.981.522.78Tangential1.552.821.452.531.522.771.592.89Axial1.452.641.402.311.582.891.412.57**At ¼ axial center**Radial1.552.831.592.941.432.611.652.83Tangential1.592.891.582.881.552.821.672.85Axial1.452.641.422.601.372.501.422.60Table 3Extra spatial resolution values (NEMA NU 4-2008).Reconstructed image pixel size (mm): 0.25 mm\
Slice thickness (mm): 0.25 mm\
At axial center0 mm50 mm75 mm100 mmFWHMFWTMFWHMFWTMFWHMFWTMFWHMFWTMRadial1.572.941.673.001.642.991.642.99Tangential1.532.901.512.751.763.021.663.21Axial1.362.621.442.631.442.631.442.63**At ¼ axial center**Radial1.562.851.803.221.703.091.853.34Tangential1.562.841.853.321.763.271.693.07Axial1.422.581.452.501.502.811.552.83Table 4Spatial resolution (NEMA NU 2-2012).Reconstructed image pixel size (mm): 0.25 mm\
Slice thickness (mm): 0.25 mm\
At axial center10 mm100 mmFWHMFWTMFWHMFWTMRadial1.873.391.864.83Tangential1.683.071.913.43Axial1.392.541.402.56**At 3/8 axial center**Radial1.824.561.975.42Tangential1.773.231.853.38Axial1.372.501.452.64

Scatter fraction and count rate measurements {#Sec10}
--------------------------------------------

Figure [4](#Fig4){ref-type="fig"} shows the count rate curves as a function of the activity according to NU 2-2012 protocol. Noise Equivalent Count Rate measurement (NECR) peak achieved 49 kcps\@287 MBq while the true peak was 193 kcps\@287 MBq. The SF had a mean value of 48% for CareMiBrain system in a range of activities of 7.4--14.8 MBq.Figure 4Count rate curves NU 2-2012.

Sensitivity {#Sec11}
-----------

The results for NU 4-2008 are shown in Fig. [5a](#Fig5){ref-type="fig"}. The sensitivity peak was 7% (for 30% of energy window) and 10% (for 50%). According to the NU 2-2012, the total sensitivity in the center was 13.82 cps/kBq and 11.05 cps/kBq (for 50% and 30% respectively), while 17.83 cps/kBq and 13.57 cps/kBq respectively at 100 mm-off-center as shown in Fig. [5b](#Fig5){ref-type="fig"}.Figure 5(**a**) Sensitivity according to preclinical standard (solid source). (**b**) Percentage of total activity acquired by each slice measured according to WB-PET standard in the center of the FOV.

To compare both protocols, the average of the contributions of the ^22^Na source along the whole axial axis can be considered as an approximation of the sensitivity of a line source of 154 mm (5.69% and 3.59% for the 50% and 30% energy windows respectively). If we consider the liquid source homogeneous, the activity in the 154 mm FOV can be linearly estimated (*i*.*e*. 154/700 times the original activity). The values obtained with this estimation were similar: 1.25% vs. 1.38% for the 50% window and 0.79% vs. 1.10% for the 30% window. The difference between the measurements could be reduced with a higher sampling of the ^22^Na data, which would lead to a better approximation to a line source.

Image quality, the accuracy of attenuation, and scatter corrections {#Sec12}
-------------------------------------------------------------------

The results for the recovery coefficients were 0.73, 0.78, 1.14 and 1.01 (from smaller to bigger rod diameters) with standard deviations of 45--46% for all rods. The SOR were 0.002 and 0.0001 with standard deviations of 12.3% and 17% for air and water respectively. The patient image is shown in Fig. [6](#Fig6){ref-type="fig"}.Figure 6Patient image from Hospital Clínico San Carlos (Spain).

Comparison with other tomographs {#Sec13}
--------------------------------

The most relevant characteristics of the brain dedicated and WB-PET systems are listed in Table [5](#Tab5){ref-type="table"}, and NEMA results in Tables [6](#Tab6){ref-type="table"} and [7](#Tab7){ref-type="table"}. There is no consensus on the image quality study for dedicated brain PETs and any work found in the literature present results for the NEMA "accuracy" section. These results for WB-PETs are given in Table [8](#Tab8){ref-type="table"}, for completeness (procedures and phantoms are in NU 2-2007 and NU 2-2012).Table 5PET systems characteristics.PET Name (company)TypeScintillatorCrystal Size (mm)SensoraFOV (mm)tFOV (mm)NEMA standardCareMiBrain (Oncovision)Brain PETLYSO50 × 50 × 12SiPM1542402012 & 2008BrainPET-4layers-MPPC-DOI^[@CR13]^Brain PET4 layer LYSO1.2 × 1.2 × 3, 4, 5 & 8MPPC201,63302008 OR 2012NeuroPET^[@CR14]^Brain PET\\CTLYSO:Ce2.3 × 2.3 × 10SiPM2202502008 OR 2012Human Brain Insert (Siemens)^[@CR15]^Brain PET InsertLSO2.5 × 2.5 × 20APD1913202007G-PET^[@CR16]^Brain PETGSO4 × 4 × 10PMT2563002001 OR 1994ECAT HRRT^[@CR17]^Brain PET2 layers LSO/LYSO2 × 2 × 10 & 10PMT2303202001jPET-D4^[@CR18]^Brain PET4 layers GSO2.9 × 2.9 × 7.5PS-PMT3122602001GAPD-PET^[@CR19]^Brain PETLYSO3 × 3 × 20GAPD603902007 OR 2008PET-HAT^[@CR20]^Brain PET2layers GSO4.9 × 4.9 × 7 & 8PF-PMT481802001MB-PET^\*^ ^[@CR21]^Brain PETLYSO:Ce1 × 1 × 10---2453102008MindView^[@CR22]^Brain PET InsertLYSO50 × 50 × 20SiPM154220NO NEMARF-penetrable PET insert^[@CR23]^Brain PET InsertLYSO3.2 × 3.2 × 20SiPM280---NO NEMARainbow VHD (PINGSENG)^[@CR24]^Brain PETLYSO:Ce2.88 × 2.88 × 18PMT119300NO NEMAHelmetPET^[@CR25]^Helmet brain PETLYSO:Ce1.5 × 1.5 × 10MPPC48185NO NEMASBPET^\*^ ^[@CR26]^Spherical brain PETLiquid Xenon32 × 50 × 100---250---NO NEMAHelmet Jaw PET^\*^ ^[@CR27]^Helmet-Jaw PET---3 × 3 × 3---------NO NEMAHelmet-chin PET^\*^ ^[@CR28]^Helmet-Chin PET4 layers GSO2.8 × 2.8 × 7.5---------NO NEMANeuro-PET^[@CR29]^Brain PETLYSO3 × 3 × 20SiPM60---NO NEMACelestion (Toshiba)^[@CR30]^PET/CTLYSO4 × 4 × 4PMT1967002012Biograph mCT flow (Siemens)^[@CR31]^PET/CTLSO4 × 4 × 20PMT2217002012Biograph mCT (Siemens)^[@CR32]^PET/CTLSO4 × 4 × 20PMT2217002012Biograph mMR (Siemens)^[@CR33]^PET-MRLSO4 × 4 × 20PMT2585882007Vereo (Philips)^[@CR34]^PET/CTLYSO4 × 4 × 19DPC1647642012Ingenuity TF (Philips)^[@CR35]^PET/CTLYSO4 × 4 × 22PMT180256, 576, 6762007Ingenuity PET/MR (Philips)^[@CR36]^PET/MRLYSO4 × 4 × 22PMT1806752007Geminity TF (Philips)^[@CR37]^PET/CTLYSO4 × 4 × 22PMT1806752007SIGNA PET/MR (GE)^[@CR38]^PET/MRLBS4 × 5.3 × 25SiPM2506002012Discovery MI (GE)^[@CR39]^PET/CTLYSO4 × 5.3 × 25SiPM200 mm700 mm2012Discovery IQ (GE)^[@CR40]^PET/CTBGO6.3 × 6.3 × 30PMT200 mm700 mm2012\*Simulated devices.Table 6Spatial resolution (center axial FOV).PET NameAlgorithmIsotope10 mm100 mmFWHMFWTMFWHMFWTMradialtang.axialradialtang.axialradialtang.axialradialtang.axialCelestionSSRB + FBP^18^F4.54.74.4\<5.0\<5.1\<5.14.64.84.6\<5.4\<5.2\<5.1Biograph mCT flowFORE + FBP^18^F4.334.334.258.608.608.555.164.725.859.309.6811.06Biograph mCTFORE + FBP^18^F5.05.06.410.810.811.84.94.95.79.39.310.7Biograph mMRFORE + FBP^18^F4.04.04.18.08.08.24.44.44.48.38.38.8Vereos3DFRP^18^F3.993.993.998.29------------------------Ingenuity TF3DFRP^18^F4.844.844.739.799.799.675.255.015.2310.5510.0810.48Ingenuity PET/MR3DFRP^18^F4.74.74.69.49.49.55.05.35.09.910.59.7Geminity^18^F5.064.844.739.79.79.65.034.895.210.310.29.6SIGNA PET/MRFBP^18^F4.44.105.34---------5.784.446.74---------Discovery MIFBP^18^F4.023.974.398.528.1910.125.284.235.639.958.8311.80Discovery IQOSEM (VPHD)^18^F4.24.74.89.59.811.25.65.14.811.410.211.1**Dedicated PETs**CareMiBrainSSRB + 2DFBP^22^Na1.721.661.713.133.023.112.652.201.745.906.904.80CareMiBrainSSRB + 2DFBP^18^F2.341.931.944.275.202.514.263.513.547.809.404.57BrainPET-4layer MPPC2DFBP^22^Na1.8--2.11.8--2.11.8--2.1---------1.8--2.11.8--2.11.8--2.1---------NeuroPETFBP^22^Na3.23.23.56.06.06.85.23.14.06.84.86.2Human Brain InsertOP-3DOSEM^18^F1.82.92.75.87.011.03.66.04.45.711.59.5G-PET3D-FRP4.24.25.210.010.08.25.05.06.012.212.210.2ECAT HRRT2D FBP^18^F2.62.73.0---------3.03.15.1---------jPET-D4SSRB + 2DFBP^18^F3.13.13.1---------3.73.53.1---------GAPD-PET^22^Na3.03.0------------4.63.3------------PET-HATSSRB + 2DFBP^22^Na4.04.0------------4.24.2------------MB-PETMLEM^22^Na1.021.211.27---------1.281.412.05---------Table 7Count rate evaluation and sensitivity.PET systemNECR Peak\
(kcps)NECR \[A\]\
(kBq/ml)True Peak\
(kcps)True \[A\]\
(kBq/ml)Scatter Fraction\
(%)E. Window\
(keV)Sens. Center\
(cps/kBq)Sens. 100 mm\
(cps/kBq)Celestion70.29.6220---33---3.83.8Biograph mCT flow185.29.063442.433.5---9.69.6Biograph mCT186.30.1------37.7 (NECR)---13.313.1Biograph mMR196.24.4------37.9 (NECR)---10.010.0Vereos157.652.8625---31.6---5.395.41Ingenuity TF124.20.3364.535.030.4---7.397.28Ingenuity PET/MR88.513.7------26---7.27.00Geminity112.15 0.0264.16.5224.7---7.97.9SIGNA PET/MR218.217.8------43.6---22.523.3Discovery MI201.122.1875.935.440.4---13.414.0Discovery IQ123.9.1490.125.836---20.4322.8**Dedicated PETs**CareMiBrain49287 MBq193287 MBq48355--66411.0513.57BrainPET-4L-MPPC44.717.5 kBq------48.3---21.423.7NeuroPET22.72.9------------11.613.9Human Brain Insert30.77.332322.738--42---7.2%7.9%G-PET607.4013213.6930--46---4.79 (peak at 0.08)---ECAT HRRT45---50015------2.5% (absolute)2.7% (absolute)jPET-D4828.7------42400--60019.3---GAPD-PET------------------------PET-HAT0.82---------60---0.72% (^22^Na, center)---MB-PET------------48350--60037 (total, ^22^Na)---Table 8PET image quality (contrast recovery) for different sphere diameters (whole-body PETs).PET NameContrast Recovery (Background Variability)10 mm13 mm17 mm22 mm28 mm37 mmRelative count rate error at NECR-peak (%)Celestion27,9 (6,2)48,6 (5,3)52,0 (4,6)60,5 (4,1)72,9 (3,9)77,1 (3,8)17.3 (TOF-LM-OSEM)Biograph mCT flow28,5 (24,3)42,3 (42,6)58,4 (568,35)71,7 (70,7)70,1 (70,3)78,3 (78,25)3.7 (FORE-FBP)Biograph mCT376672,277,38185,31.9 (FORE-FBP)Biograph mMR23,457,175,28358,867,54.9 (FPRE-FBP)Vereos38,4 (8.4)61,3 (7.1)65,9 (5,9)68.5 (4,6)83,4 (3,5)86,4 (2,8)---Ingenuity TF0,390,730,740,80,840,81---Ingenuity PET/MR30 (7)50 (6)61 (4)70 (3)78 (3)81 (3)---Geminity34,70 (8,65)51,43 (7.89)60,83 (7.05)72,13 (6.15)73.88 (5.46)77.65 (5.04)SIGNA PET/MR35,2 (4,9)48,9 (4,0)59,9 (3,2)68,6 (2.7)79,2 (2.2)87.4 (1.9)3.3 (OSEM)Discovery MI51.7 (10)61.5 (7.8)66.2 (6.0)81.3 (4.8)86.6 (3.8)90.0 (3.0)2--3 (not in NECR-peak)Discovery IQ22 (3.3)68 (2.0)68 (2.0)76 (2.5)73 (2.5)81 (2.5)3.9 (OSEM)

Discussion {#Sec14}
==========

Dedicated brain PETs present better results than WB-PETs in spatial resolution tests, CareMiBrain being the system that reports the best results. When both protocols are compared, the solid source results improve when compared with liquid sources (with larger dimensions). The use of ^22^Na solid source is easier, cost-effective (even ecological) compared to ^18^F liquid sources. For logistical reasons, we recommend a ^22^Na source. Since the results are sensitive to the reconstruction algorithm (2D-FBP, 3D-FBP, rebinning, filters, etc.) it could be interesting to perform this test free of algorithmic dependence *i*.*e*., Siddon-like-back-projection^[@CR12]^ or just Full Width at Half Maximum (FWHM) measurements in the data sinograms.

Regarding count rate measurements, WB-PETs present a higher NECR peak and lower SF than dedicated brain PETs in all cases, but total count rates are comparable. The scatter detection is related to the system geometry, and smaller gantry translates into greater SF. The NECR curve depends (in the denominator) on the scatter, therefore, its peak is smaller for smaller gantry systems even if the total count rates are similar. The SF for CareMiBrain is in the range of other brain PET systems and NECR and trues peaks are overcome by jPET and G-PET. All systems have used NU 2-2012 phantom for the counting rate performance test and that is the main reason to use it in the present study. Figure [6](#Fig6){ref-type="fig"} shows a patient image from CareMiBrain system, acquired at typical injection activity for a dedicated brain PET study, far below the NECR peak measured. Usually, dedicated PETs work at lower rates than the whole-body systems due to its proximity to the organ of study, allowing a higher frequency of patient monitoring.

Signa PET and Discovery IQ report the best results for the sensitivity test, and the brainPET 4 layers MPPC DOI, followed by jPET, NeuroPET and CareMiBrain present the best results for dedicated brain PETs. Finally, the values for the recovery coefficients showed an acceptable performance for attenuation and scatter corrections with the proposed measurements.

Conclusion {#Sec15}
==========

Dedicated brain PET systems improve spatial resolution and sensitivity, but present worse results in count rate measurements and scatter fraction tests. However, the study should be re-performed for all the tomographs with a different phantom that appropriately adjusts the dimensions and characteristics of the brain to draw further conclusions for brain devices.

NEMA standards are an extremely useful tool for the comparison of different PET scanners, but, given the emerging dedicated brain PET systems, it could be interesting to redefine a standard exclusively for these tomographs. Comparing standards, the results are similar and we recommend the use of the solid sources due to logistic reasons.

In view of the results, performance characteristics of CareMiBrain system are at top of the current PET technologies.
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